期刊文献+

丹红注射液活性成分与阿尔茨海默病脑内胰岛素抵抗的相关性 被引量:5

Correlation between Active Ingredient of Danhong Injection and Insulin Resistance in Brain of Alzheimer's Disease
下载PDF
导出
摘要 目的:探讨丹红注射液药物组成丹参红花主要成分与阿尔茨海默病(Alzheimers disease,AD)脑内胰岛素抵抗之间的相关性。方法:查阅相关文献,阿尔茨海默病涉及的神经系统广泛,已认识到胰岛素可通过PI3K/PKB途经改变糖原合成激酶(GSK-3β)的磷酸化状态进而调节其活性,激活的PKB引起GSK-3β在Ser位点磷酸化失活起关键作用。结果:阿尔茨海默病的发生是渐进性的神经退行性变过程,难用单一高选择性、高亲和力和作用特异药物调节AD。中医药有可能发挥独特的作用。结论:丹参红花多成分、多靶点、多通路的特性,使其有望从中寻找出疗效满意、作用靶点明确的新型神经保护剂。 Objective : To investigate the correlation between Salvia and safflower main ingredient and insulin resistance in the brain of Alzheimer's disease. Methods : By reading the related documents, Alzheimer's disease involves a wide range of nervous system. Insulin has been recognized by changing glycogen synthase kinase (GSK -3β) phosphorylation status through the PI3K/PKB thereby regulating its activity. PKB activation and plays a key role of GSK -3β phosphorylation site at Ser inactivation. Results : Alzheimer's disease is a progressive neurodegenerative process. It' s difficult to use a sin- gle drug with high selectivity, high affinity and specific action regulating AD. Traditional Chinese medicine may play a u- nique role. Conclusions:The characteristics of Danhong by multi -component,multi -target and multi -channel makes it be expected to look for a satisfactory outcome, specifically new neuroprotective agents.
机构地区 浙江中医药大学
出处 《中华中医药学刊》 CAS 北大核心 2016年第11期2590-2592,共3页 Chinese Archives of Traditional Chinese Medicine
基金 国家自然科学基金项目(81630105 81403284 81473587) 浙江省自然科学基金项目(LR16H270001) 浙江省中医药科技计划项目(2013ZA029)
关键词 胰岛素抵抗 PI3K/PKB 阿尔茨海默病 丹红活性成分 insulin resistance PI3 K/PKB Alzheimer disease Danhong active ingredient
  • 相关文献

参考文献20

  • 1商永华,刘海云.丹红注射液对慢性脑缺血大鼠脑组织丙二醛、谷氨酸及GSH-PX的影响[J].海峡药学,2008,20(7):43-45. 被引量:4
  • 2Reddy PH, Manczak M, Mao P, et al. Amyloid - β and mitochon- driain aging and Alzheimer' s disease : Implications for synaptic damage and cognitive decline [ J ]. Alzheimers Dis, 2010,20 (8) :499 -512.
  • 3Claudine L, William L, Peter H, et al. Amyloid - β and Tau Pa- thology of Alzheimer's Disease Induced by Diabetes in an Animal Model[ J]. Alzheimers Dis,2012,10(3 ) :3233 - 3235.
  • 4Lester- CoU, Arash N. Intracerebral streptozotocin model of type 3 diabetes:relevance to sporadic Alzheimer disease[ J]. Alzhei- mers Dis ,2012,9 ( 1 ) : 13 - 33.
  • 5Matsuzaki ,Arash T. Insulin resistance is associated with the pa- thology of Alzheimer disease [ J ]. Hisayama study Neurology, 2010,75 (9) :764 - 770.
  • 6Llovera RE, Alonso L. The catalytic domain of insulin - degrading enzyme forms adenaturantresistant complex with amyloid peptide: implications for Alzheimer disease pathogenesis[ J]. Biol Chem, 2008,28(25) :1739 - 1748.
  • 7Willette, Mao A. Insulin resistance, brain atrophy, and cognitive performance in late middle - aged adults [ J ]. Diabetes Care, 2012,36(2) : 439 -443.
  • 8Behnam Sabayan, Farzaneh Foroughinia, Arash Mowla, et al. Role of insulin metabolism disturbances in the development of alzheimer disease [ J ]. American Journal of A Alzheimer's Dis- ease and Other Dementias,2008,23 (2) : 192 -199.
  • 9Konrad TR. An anti - diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimerg disease - associated Abeta oligomers [ J ]. Clin Invest, 2012,12 ( 4 ) : 1339 - 1353.
  • 10Felice, D. L. , T.G. Unterman, Nuclear receptor regulation of bile acid and nutrient metabolism: 51 st Annual Max Miller Lec- ture in Diabetes Research[ J]. Transl Res,2012,32(8 ) :137 - 139.

二级参考文献61

共引文献159

同被引文献61

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部